# Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer

> **NCT03819088** · NA · COMPLETED · sponsor: **Emory University** · enrollment: 17 (actual)

## Conditions studied

- Gastric Carcinoma
- Liver and Intrahepatic Bile Duct Carcinoma
- Unresectable Esophageal Carcinoma
- Unresectable Pancreatic Carcinoma

## Interventions

- **DIETARY_SUPPLEMENT:** Zinc

## Key facts

- **NCT ID:** NCT03819088
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-17
- **Primary completion:** 2021-10-05
- **Final completion:** 2022-03-22
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-10-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03819088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03819088, "Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03819088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*